{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:37:57Z","timestamp":1788871077667,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.healun.2009.11.001","type":"journal-article","created":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T04:08:38Z","timestamp":1262318918000},"page":"562-567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Treatment with telmisartan attenuates graft arteriosclerosis in murine cardiac allografts"],"prefix":"10.1016","volume":"29","author":[{"given":"Hisanori","family":"Kosuge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go","family":"Haraguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Maejima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Saiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuaki","family":"Isobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2009.11.001_bib1","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.healun.2006.05.002","article-title":"Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult heart transplantation report\u20142006","volume":"25","author":"Taylor","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2009.11.001_bib2","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1161\/01.CIR.96.6.2069","article-title":"Cardiac allograft vasculopathy: a review","volume":"96","author":"Weis","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2009.11.001_bib3","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1161\/01.RES.80.5.607","article-title":"Angiotensin II signal transduction in vascular smooth muscle: role of tyrosine kinases","volume":"80","author":"Berk","year":"1997","journal-title":"Circ Res"},{"key":"10.1016\/j.healun.2009.11.001_bib4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International union of pharmacology","volume":"52","author":"de Gasparo","year":"2000","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.healun.2009.11.001_bib5","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.jacc.2003.11.060","article-title":"Angiotensin II receptors from peritransplantation through first-year post-transplantation and the risk of transplant coronary artery disease","volume":"43","author":"Yousufuddin","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2009.11.001_bib6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ehj.2004.01.005","article-title":"Cardiac angiotensin II receptors as predictors of transplant coronary artery disease following heart transplantation","volume":"25","author":"Yousufuddin","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2009.11.001_bib7","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.healun.2006.09.012","article-title":"Increased expression of angiotensin II type 1 receptor (AGTR1) in heart transplant recipients with recurrent rejection","volume":"25","author":"Yamani","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2009.11.001_bib8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jss.2005.07.011","article-title":"The angiotensin II type 1 receptor blocker candesartan attenuates graft vasculopathy","volume":"132","author":"Yamamoto","year":"2006","journal-title":"J Surg Res"},{"key":"10.1016\/j.healun.2009.11.001_bib9","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S1053-2498(00)00197-2","article-title":"New approach in the therapy of chronic rejection?","volume":"19","author":"Richter","year":"2000","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2009.11.001_bib10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s00395-004-0489-0","article-title":"The angiotensin II type 1 receptor blocker valsartan attenuates graft vasculopathy","volume":"100","author":"Yamamoto","year":"2005","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.healun.2009.11.001_bib11","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/01.CIR.0000127955.36250.65","article-title":"Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity","volume":"109","author":"Schupp","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2009.11.001_bib12","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1161\/01.CIR.0000039346.31538.2C","article-title":"Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction","volume":"106","author":"Shiomi","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2009.11.001_bib13","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/01.ATV.21.3.372","article-title":"Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: pleiotropic effects on CD36 expression and HDL","volume":"21","author":"Chen","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.healun.2009.11.001_bib14","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/hc1002.105225","article-title":"Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo","volume":"105","author":"Asakawa","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2009.11.001_bib15","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0008-6363(03)00457-7","article-title":"Peroxisome proliferation-activated receptor-gamma ligands ameliorate experimental autoimmune myocarditis","volume":"59","author":"Yuan","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.healun.2009.11.001_bib16","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1172\/JCI118991","article-title":"Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia","volume":"98","author":"Law","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.healun.2009.11.001_bib17","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.4049\/jimmunol.164.3.1364","article-title":"The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses","volume":"164","author":"Clark","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.healun.2009.11.001_bib18","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1161\/01.RES.83.11.1097","article-title":"Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells","volume":"83","author":"Marx","year":"1998","journal-title":"Circ Res"},{"key":"10.1016\/j.healun.2009.11.001_bib19","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1161\/01.CIR.0000074040.31731.96","article-title":"Inhibitory activity of clinical thiazolidinedione peroxisome proliferator activating receptor-gamma ligands toward internal mammary artery, radial artery, and saphenous vein smooth muscle cell proliferation","volume":"107","author":"de Dios","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2009.11.001_bib20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/01.CIR.101.3.235","article-title":"Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators","volume":"101","author":"Pasceri","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2009.11.001_bib21","doi-asserted-by":"crossref","first-page":"34176","DOI":"10.1074\/jbc.M203436200","article-title":"Constitutive activation of peroxisome proliferator-activated receptor-gamma suppresses pro-inflammatory adhesion molecules in human vascular endothelial cells","volume":"277","author":"Wang","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.healun.2009.11.001_bib22","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1161\/CIRCULATIONAHA.105.594101","article-title":"Pioglitazone prevents acute and chronic cardiac allograft rejection","volume":"113","author":"Kosuge","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2009.11.001_bib23","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1161\/01.CIR.84.3.1246","article-title":"Early detection of rejection and assessment of cyclosporine therapy by indium-111 antimyosin imaging in mouse heart allografts","volume":"84","author":"Isobe","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2009.11.001_bib24","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1034\/j.1600-6143.2003.00164.x","article-title":"Tumor necrosis factor receptor-1 and -2 double deficiency reduces graft arterial disease in murine cardiac allografts","volume":"3","author":"Suzuki","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2009.11.001_bib25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/01.CIR.87.1.261","article-title":"Inhibition of accelerated coronary atherosclerosis with dehydroepiandrosterone in the heterotopic rabbit model of cardiac transplantation","volume":"87","author":"Eich","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2009.11.001_bib26","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.4049\/jimmunol.165.6.3506","article-title":"Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis","volume":"165","author":"Shimizu","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.healun.2009.11.001_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1477-7827-5-27","article-title":"Spatio-temporal expression of MMP-2, MMP-9 and tissue kallikrein in uteroplacental units of the pregnant guinea-pig (Cavia porcellus)","volume":"5","author":"Corthorn","year":"2007","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.healun.2009.11.001_bib28","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1681\/ASN.2005090955","article-title":"Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation","volume":"17","author":"Heinze","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.healun.2009.11.001_bib29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0966-3274(01)00028-4","article-title":"Candesartan cilexetil reduces graft arteriosclerosis in aortic transplantation model in rat","volume":"8","author":"Zezina","year":"2001","journal-title":"Transplant Immunol"},{"key":"10.1016\/j.healun.2009.11.001_bib30","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1161\/01.HYP.0000157409.88971.fc","article-title":"Inhibitory effects of AT1 receptor blocker, olmesartan, and estrogen on atherosclerosis via anti-oxidative stress","volume":"45","author":"Tsuda","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.healun.2009.11.001_bib31","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0002-9440(10)64559-2","article-title":"Association of B7-1 co-stimulation with the development of graft arterial disease","volume":"157","author":"Furukawa","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.healun.2009.11.001_bib32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/01.tp.0000188139.11931.98","article-title":"An antagonist mutant IL-15\/Fc promotes transplant tolerance","volume":"81","author":"Zheng","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2009.11.001_bib33","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0008-6363(02)00592-8","article-title":"Expression of matrix metalloproteinases in cardiac allograft vasculopathy and its attenuation by anti MMP-2 ribozyme gene transfection","volume":"56","author":"Tsukioka","year":"2002","journal-title":"Cardiovasc Res"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105324980900850X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105324980900850X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T15:12:17Z","timestamp":1762355537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105324980900850X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S105324980900850X"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2009.11.001","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment with telmisartan attenuates graft arteriosclerosis in murine cardiac allografts","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2009.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}